Author
The author is CEO, AIRA Matrix
Artificial Intelligence can optimise diagnostic workflows by augmenting non-invasive investigative modalities. Histopathological examination of biopsy tissue with ancillary procedures, is considered the gold standard for cancer diagnosis.
Read More
Deep Learning techniques are well suited to make a difference in complex, expensive processes like drug development.
Read More
